Related Experiment Video

Updated: Jul 17, 2026

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
08:24

The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies

Published on: August 25, 2023

Immortal time bias in observational studies of drug effects

Samy Suissa1

  • 1McGill Pharmacoepidemiology Research Unit, McGill University Health Centre, Montreal, Canada. samy.suissa@clinepi.mcgill.ca

Pharmacoepidemiology and Drug Safety
|January 26, 2007
PubMed
Abstract

Insights

Immortal time bias in observational studies can create a false impression of drug effectiveness. Re-evaluating studies on cardiovascular disease (CVD) treatments is crucial to correct for this bias.

Area of Science:

  • Epidemiology
  • Biostatistics

Background:

  • Observational studies increasingly suggest drug efficacy in reducing morbidity and mortality.
  • However, flawed study design and data analysis, particularly immortal time bias, can distort findings.
  • This bias can erroneously attribute effectiveness to unrelated treatments.

Purpose of the Study:

  • To describe immortal time bias in observational research.
  • To illustrate how this bias can falsely suggest effectiveness for unrelated drugs in treating cardiovascular disease (CVD).

Main Methods:

  • A cohort of 3315 patients with chronic obstructive pulmonary disease (COPD) hospitalized for CVD was analyzed.
  • The study assessed the impact of gastrointestinal drugs (GID) and inhaled beta-agonists (IBA) on all-cause mortality using both a biased and a proper person-time approach.
  • Comparison of results from both methods aimed to highlight the effect of immortal time bias.

Main Results:

  • The biased approach suggested IBA and GID reduced mortality (Rate Ratios: 0.73 and 0.78, respectively).
  • Proper person-time analysis yielded Rate Ratios close to 1 (0.98 for IBA, 0.94 for GID), indicating no significant effect.
  • This demonstrates how immortal time bias can create an illusion of treatment benefit.

Conclusions:

  • Immortal time bias is a significant flaw in many observational studies, potentially generating false positive results for drug effectiveness.
  • There is a critical need to re-assess observational studies reporting surprising benefits, especially for cardiovascular disease (CVD) treatments, to account for this bias.
  • Correcting for immortal time bias is essential for accurate interpretation of drug efficacy in real-world data.

More Related Videos

The Power of Interstimulus Interval for the Assessment of Temporal Processing in Rodents10:27

The Power of Interstimulus Interval for the Assessment of Temporal Processing in Rodents

Published on: April 19, 2019

Related Concept Videos

Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...